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Summary
Three distinct isoforms of pantothenate kinase (CoaA)
in bacteria catalyze the first step in coenzyme A bio-
synthesis. The structures of the type II (Staphylococ-
cus aureus, SaCoaA) and type III (Pseudomonas aeru-
ginosa, PaCoaA) enzymes reveal that they assemble
nearly identical subunits with actin-like folds into di-
mers that exhibit distinct biochemical properties.
PaCoaA has a fully enclosed pantothenate binding
pocket and requires a monovalent cation to weakly
bind ATP in an open cavity that does not interact
with the adenine nucleotide. Pantothenate binds to
an open pocket in SaCoaA that strongly binds ATP
by using a classical P loop architecture coupled with
specific interactions with the adenine moiety. The Pa-
CoaAPan binary complex explains the resistance of
bacteria possessing this isoform to the pantothena-
mide antibiotics, and the similarity between SaCoaA
and human pantothenate kinase 2 explains the molec-
ular basis for the development of the neurodegenera-
tive phenotype in three mutations in the human
protein.
Introduction
Coenzyme A (CoA) is an indispensable cofactor in all bi-
ological systems, where it functions as the major acyl
group carrier (Leonardi et al., 2005b). The universal
CoA biosynthetic pathway consists of five enzymatic
steps, the first of which is the phosphorylation of panto-
thenate (Pan), or vitamin B5, catalyzed by pantothenate
kinase. Pantothenate kinase is the key regulatory step in
CoA biosynthesis (Leonardi et al., 2005b). The eukary-
otic pantothenate kinase isoforms (PanKs) are distinct
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300-0393, Japan.from their bacterial counterparts (Calder et al., 1999),
and they are feedback inhibited by CoA or its thioesters
to achieve a tight and tissue-specific regulation of the
cofactor level (Rock et al., 2000, 2002; Zhang et al.,
2005).
Bacteria possess three types of pantothenate kinases
(CoaAs) that differ in sequence, regulation, substrate af-
finity, and specificity (Brand and Strauss, 2005; Leonardi
et al., 2005a; Vallari et al., 1987). The type I CoaA is
widely distributed, and the prototypical member is the
Escherichia coli CoaA (EcCoaA), which is encoded by
the coaA gene (Song and Jackowski, 1992, 1994) and
is regulated through feedback inhibition by CoA and
CoA thioesters (Vallari et al., 1987). EcCoaA is a dimer
of identical subunits and is structurally classified as
a P loop kinase containing a Walker A motif (Ivey et al.,
2004; Yun et al., 2000). The pantothenate kinase from
Staphylococcus aureus (SaCoaA) is the prototypical
type II enzyme, and it is refractory to feedback inhibition
by CoA or its thioesters (Leonardi et al., 2005a). This lack
of regulation allows the accumulation of millimolar con-
centrations of CoA, which is the major intracellular thiol
in this organism (delCardayre et al., 1998). There is par-
ticular interest in the type II SaCoaA protein because it is
related to the four eukaryotic isoforms of pantothenate
kinase, PanK1a, PanK1b, PanK2, and PanK3 (Cheek
et al., 2005). Alignment of the human PanK2 and SaCoaA
sequences (Figure 1A) reveals that the region of greatest
similarity corresponds to the conserved phosphate
binding P loop DxGG(T,S)T(S,G)xxK(R,C) motif charac-
teristic of members of the acetate and sugar kinases/
Hsc70/actin (ASKHA) family (Bork et al., 1992; Kabsch
and Holmes, 1995). Finally, a number of bacteria, includ-
ing pathogens such as Helicobacter pylori and Pseudo-
monas aeruginosa, possess a type III enzyme. The type
III CoaA from H. pylori, HpCoaA, is not regulated by
CoA or its thioesters, and, unlike the type I and II CoaAs
that have similar Kms for the substrates in the micro-
molar range (Leonardi et al., 2005a; Song and Jacko-
wski, 1994), it exhibits an unusually high Km for ATP
(w10 mM) (Brand and Strauss, 2005).
The absence of any obvious sequence similarity be-
tween the three types of bacterial CoaAs, and their strik-
ingly different biochemical properties, prompted us to
investigate the structural basis of this diversity. Our
study reports the crystal structures of the type II
SaCoaAAMP-PNP complex, the type III PaCoaA apo-
enzyme, and the PaCoaAPan complex. Both enzymes
share the same actin-like monomer fold, but they asso-
ciate to form two very different dimeric architectures.
Furthermore, by combining the structural information
on how SaCoaA and PaCoaA bind the phosphoryl donor
and Pan, respectively, we can assemble an accurate
picture of the catalytic ternary complex for each en-
zyme. These models provide a structural framework
for understanding the substrate specificities of each en-
zyme and their distinct catalytic mechanisms. Both the
type I and type II CoaAs recognize the pantothenamide
class of antimetabolites (Leonardi et al., 2005a; Strauss
and Begley, 2002), whereas the type III CoaAs do not
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Strauss, 2005). The different dimeric structures of
SaCoaA andPaCoaA explain the resistance ofP. aerugi-
nosa to the pantothenamide class of drugs. Finally, the
structure of the SaCoaAAMP-PNP binary complex pro-
vides insights into the structure and catalytic mecha-
nism of the mammalian pantothenate kinases. This is
important because the human PanK2 isozyme is associ-
ated with mutations that result in the progressive neuro-
degenerative disorder known as PKAN (pantothenate ki-
nase-associated neurodegeneration) (Zhou et al., 2001),
and we can now provide insights into the structural
basis for the enzyme inactivation by these mutations.
Results and Discussion
Overall Structures of SaCoaA and PaCoaA
The crystal structures ofSaCoaA andPaCoaA were both
determined by MAD phasing and were subsequently re-
fined to 2.05 and 2.2 A˚, respectively (Tables S1 and S2;
Figure 1. Alignment of Type II and Type III CoaAs
(A) Alignment of the primary sequences of SaCoaA and human
PanK2. Residues highlighted in red were investigated by site-di-
rected mutagenesis, and those indicated with an asterisk (*) are con-
served between SaCoaA and human PanK2 and are mutated in
PKAN patients. The residues in the dimer interface conserved be-
tween the two proteins are indicated with a ‘‘+.’’
(B) Alignment of the primary sequences of the type III CoaAs from
P. aeruginosa (NCBI gij15599475), B. subtilis (NCBI gij16077138,
corrected in GenBank acc. #AY912104), and H. pylori (NCBI
gij15645481). Sequence identities are: PaCoaA/BsCoaA = 19%,
PaCoaA/HpCoaA = 21%, HpCoaA/BsCoaA = 14%, and PaCoaA/
SaCoaA = 12%. The residues in the dimer interface conserved in
at least two of the three sequences are indicated with a ‘‘+.’’see the Supplemental Data available with this article on-
line). The monomer structures are very similar and com-
prise two a/b domains, and each domain contains
a mixed five-stranded b sheet surrounded by a helices
(Figures 2A and 2C). Domain I consists of strands b1–
b5 in the order 3-2-1-4-5 with strand b2 antiparallel to
the others, and helices a1, a2, a3, and a8. Domain II con-
tains strands b6–b10 in the order 8-7-6-9-10 with strand
b7 antiparallel to the others, and helices a3, a4, a5, a6,
a7, and a8. The folding topologies of each domain are
identical and place them in the actin superfamily. They
are tightly associated such that helices a3 and a8 are
common to each domain at the domain interface, with
the C-terminal a8 completing the domain I substructure.
A structural similarity search of the protein database
with the VAST program revealed that the fold of SaCoaA
and PaCoaA places them in the ASKHA superfamily
(Bork et al., 1992; Cheek et al., 2002; Kabsch and
Holmes, 1995). Members of this family have the same
relative orientations of domains I and II. The classic P
loops in the kinase fold are between the first and second
b strands of each domain (strands b1 and b2 of domain I
and strands b6 and b7 of domain II), and these meet at
the center of the domain interface. The domain I P
loop has the classical signature sequence, whereas do-
main II can be considered a ‘‘pseudo kinase’’ domain.
Domain II is larger than domain I by virtue of two addi-
tional helices, a4 and a5, and an extended a6 compared
to its counterpart, a1 (Figures 2A and 2C).
Both proteins crystallized as a dimer in the asymmet-
ric unit, and the monomers of this dimer are related by
a noncrystallographic 2-fold rotation axis. The dimen-
sions of the dimers are consistent with the hydrody-
namic data on the two soluble proteins (Figure S1) (Leo-
nardi et al., 2005a). Although the SaCoaA and PaCoaA
monomers have very similar structures, they each con-
tain a loop region that is absent from the other enzyme,
which results in their assembly into dimers with dis-
tinctly different architectures (Figures 2B and 2D). Sa-
CoaA contains a loop between helices a4 and a5 that
packs against a6 (Figure 2B). Conversely, PaCoaA has
a loop inserted between b5 and a3 that contains a short
b ribbon that associates with the outside b8 strand of the
domain II b sheet (Figure 2D). Although both loops con-
tribute to the monomer-monomer interface, they do so
in different ways. The SaCoaA loop mainly interacts
with a40, whereas the PaCoaA loop interacts with the
a50–a60 loop (the prime sign indicates an element in the
other monomer). As a result, the long a6 helices within
the SaCoaA dimer interact extensively via a parallel
coiled coil (Figure 2B), whereas the same helices in the
PaCoaA dimer interact at a 70 angle and contribute
less to the dimer interface (Figure 2D).
In both the SaCoaA and PaCoaA crystal structures,
the dimer is the asymmetric unit, and their different ar-
chitectures are unlikely to be the result of crystallization
artifacts. This is supported by an analysis of the conser-
vation of the residues that mediate the different dimer in-
terfaces. ThePaCoaA interface buries 4243 A˚2 of surface
area and involves 53 residues that are highly conserved
(Figure 1B). A ‘‘fingerprint’’ of the interface is provided
by four conserved small residues that occupy tight
spaces between the monomers, glycines 139, 187, and
194, and Ala183. The latter three are within helix a6,
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(A–D) The (A) SaCoaA and (C) PaCoaA monomers are shown in identical orientations to highlight their structural similarities and their different
packing interactions with their (B and D) dimeric partners. The secondary structure elements are labeled in monomer A, and the N and C termini
are indicated. Helix a6 is shown in red, and the loops that distinguish the two monomers are shown in blue. Pan molecules are modeled according
to the PaCoaA structure and are shown with cyan carbons. The AMP-PNPMg2+ molecules modeled according to the closely related SaCoaA
structure are shown with gray carbons. Dashed lines represent residues that are not visible in the electron density. (A) The monomer structure of
SaCoaA. (B) In the SaCoaA dimer, helices a6 pack in a parallel coiled-coil arrangement. (C) The monomer structure of PaCoaA. (D) The PaCoaA
dimer forms with the central helix a6 packing against its partner at an angle of 70.and Gly194 packs against its counterpart where a6 and
a60 cross each other. InSaCoaA, the dimer interface bur-
ies 2962 A˚2 and involves 39 residues. These interface
residues are the most highly conserved in the human
PanK2 primary sequence outside of the active site
(Figure 1A), and this finding supports both the dimer
structure and the homology between SaCoaA and
PanK2. The unique loop regions in SaCoaA and PaCoaA
also support their different dimer architectures. Thus,
the SaCoaA loop cannot be accommodated in the Pa-
CoaA dimer, and the PaCoaA loop contains a highly
conserved Tyr92 that interacts with Pan (see below)
and occupies a pocket at the interface.
PaCoaA Requires a Monovalent Cation for Activity
Type I and type II CoaAs from E. coli and S. aureus, re-
spectively, catalyze the phosphorylation of pantothe-
nate in the presence of ATP and MgCl2 (Ivey et al.,
2004; Leonardi et al., 2005a; Song and Jackowski,
1994). However, PaCoaA was inactive under the same
assay conditions, suggesting that an additional cofactor
was required. The enzymatic activity of a type III CoaA
was previously measured by using a coupled assay
that included phosphoenolpyruvate, NADH, and KCl
(Brand and Strauss, 2005). We therefore tested the ef-
fect of these components on the PaCoaA activity and
found that KCl activated the enzyme. The optimal KCl
concentration was 60–120 mM (Figure 3A). The require-
ment for a monovalent cation is common to several en-
zymes that catalyze phosphoryl transfer reactions(Kachmer and Boyer, 1953; Oria-Hernandez et al.,
2005; Suelter, 1974). The majority of the enzymes requir-
ing K+ are also activated by NH4
+ and Rb+ but are poorly
activated by cations with smaller radii, such as Na+ and
Li+. PaCoaA showed a similar behavior with a strong
preference for NH4
+, which induced a 5-fold higher acti-
vation than either K+ or Rb+ (Figure 3A). The type III en-
zymes from B. subtilis (BsCoaA) and H. pylori (HpCoaA)
were also strictly dependent on the presence of NH4
+ or
K+ for activity (Figure 3B). These biochemical properties
distinguish the type III pantothenate kinases from the
type I and II CoaAs.
The kinetic parameters of PaCoaA for ATP and panto-
thenate were determined in the presence and absence
of NH4
+ to investigate the activating effect of this mono-
valent cation on the enzyme. Since the omission of NH4
+
would have completely abolished the enzymatic activity,
preventing any comparison, KCl was included in both
sets of conditions. The addition of NH4Cl had no effect
on the kinetic parameters for pantothenate (Fig-
ure S2A). Conversely, the ammonium affected both the
Km and the kcat for ATP, with an overall 4- to 5-fold in-
crease in the specificity constant for this substrate,
which accounts for the stronger activation by NH4
+
with respect to K+ (Figure 3). The Km for ATP remained
in the millimolar range even in the presence of NH4
+,
and this suggests that ATP may not be the preferred
substrate. The activity of PaCoaA was therefore as-
sayed in the presence of alternative nucleotides and
deoxynucleotides. PaCoaA utilized a wide range of
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absence of the hydroxyl group at the 20 position of the
ribose, and did not discriminate between purine- and
pyrimidine-based nucleotides or deoxynucleotides
(Figure S2B). We also tried several other phosphate do-
nors, such as acetyl-phosphate, pyrophosphate, and
phosphoenolpyruvate, as well as polyphosphates that
are used by several of the microbial actin family mem-
bers (Ding et al., 2001; Kawai et al., 2005; Tanaka et al.,
Figure 3. Monovalent Cation Requirement for Type III CoaAs
(A) The activity ofPaCoaA was assayed in reaction mixtures contain-
ing 300 ng enzyme, 100 mM HEPES (pH 7.5), 45 mM D-[1-14C]panto-
thenate, 250 mM ATP, 10 mM MgCl2, 0.1 mg/ml g-globulin, and in-
creasing concentrations of LiCl (closed circle), NaCl (open circle),
KCl (closed square), RbCl (open square), and NH4Cl (closed trian-
gle), as indicated.
(B) Comparison between the activating effect of increasing concen-
trations of KCl (closed square, open square) and NH4Cl (closed trian-
gle, open triangle) on either BsCoaA (closed square, closed triangle)
or HpCoaA (open square, open triangle) under the conditions de-
scribed in (A).
The data are the mean values from two determinations, and the error
bars represent the standard error.2003). None of these substrates supported pantothe-
nate kinase activity.
The ATP Binding Sites
In the SaCoaAAMP-PNP complex, the ATP analog
binds within the interdomain cleft of each SaCoaA
monomer (Figure 2A), and the triphosphate moiety binds
at the convergence of the P loop in domain I and the
‘‘pseudo P loop’’ in domain II. Interactions with the con-
served P loop residues are typical for a kinase, and the
key interactions are shown in Figure 4A. The main chain
nitrogen of Gly9 is hydrogen bonded to the nonbridging
oxygen of the g-phosphate, and it also interacts with the
bridging oxygen of the b-phosphate. The NZ nitrogen of
Lys13 forms hydrogen bonds with the oxygens of both
the a- and b-phosphates of AMP-PNP. A Mg2+ ion is co-
ordinated by the b- and g-phosphates of the AMP-PNP
and several water molecules, and Asp6 interacts with
the magnesium through one of these coordinating water
molecules. Thr10 is adjacent to the b-phosphate, and its
main chain nitrogen is hydrogen bonded to the non-
bridging oxygen of the b-phosphate (data not shown).
As regards interactions with the pseudo P loop, the
OG1 oxygen of Thr99 is hydrogen bonded to the bridg-
ing nitrogen of the b- and g-phosphates, and its main
chain nitrogen forms a hydrogen bond to the bridging
oxygen of the a- and b-phosphates. The main chain ni-
trogen of Gly100 forms a water-mediated hydrogen
bond with a nonbridging oxygen of the g-phosphate,
and Leu11 and Ser225 provide two additional main
chain nitrogens for interactions with the a- and b-phos-
phates. We were not successful in obtaining the struc-
ture of the PaCoaAnucleotide complex, perhaps due
to the high Km of PaCoaA for ATP, but the crystal struc-
ture of the SaCoaAAMP-PNP complex was used to
generate a model (Figure 4B). Asp6, Gly8, and Lys13 in
the PaCoaA P loop are positioned to form interactions
equivalent to those observed in SaCoaA, although
Lys13 interacts with the carbonyl group of Pro234 and
the side chain of Asp235 in the absence of nucleotide.
The classic P loop in kinases has a conserved
DxGG(T,S)T(S,G)xxK(R,C) motif that is present but not
totally conserved in SaCoaA and PaCoaA (DAGGTLIK
and DCGNSLIK, respectively). We therefore performed
mutagenesis studies to verify the roles of these nucleo-
tide binding residues that were revealed in the SaCoaA-
AMP-PNP crystal structure and predicted in the Pa-
CoaAATP model. The SaCoaA[T10A] mutant was
a less active protein, but it still bound the fluorescent
ATP analog TNP-ATP with a KD similar to that of wild-
type, consistent with the involvement of the backbone
amide, rather than the side chain, in ATP binding (Fig-
ures 5A and 5B). The SaCoaA[D6A] and SaCoaA[K13A]
mutants were both catalytically inactive and failed to
bind TNP-ATP, consistent with Asp6 coordinating the
Mg2+ required for the water-mediated ATP binding and
with Lys13 interacting with the a- and b-phosphates of
ATP (Figures 5A and 5B). Finally, the PaCoaA[K13A] mu-
tant possessed a reduced enzymatic activity, suggest-
ing a type of interaction that is not essential for ATP
binding (Figure 5C). This is further supported by the
fact that this residue is not conserved among the type
III CoaAs (Figure 1B).
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SaCoaA and PaCoaA
(A) A stereoview of the P loop region of the
SaCoaAAMP-PNP complex. The Pan mole-
cule is modeled according to the PaCoaA
crystal structure (cyan carbons). Asp6 and
Lys13 from the kinase domain P loop (bottom
right) interact with the terminal phosphates of
AMP-PNP in the usual fashion. Asn96 and
Thr99 from the pseudo P loop (top left) form
additional interactions with the phosphates.
Glu70 is the catalytic base that activates the
Pan hydroxyl.
(B) A stereoview of the PaCoaA P loop region
in the same orientation as the SaCoaA site
shown in (A). The PaCoaA active site con-
tains the pantothenate molecule from the
PaCoaAPan complex, and the AMP-
PNPMg2+ molecule is modeled according
to the SaCoaA structure. The two potassium
ions in sites 1 and 2 are modeled according to
the Hsc70 structure (Wilbanks and McKay,
1995), and the site 2 potassium is proposed
to be the monovalent cation necessary for
the reaction to proceed. Note that the side
chains and water molecules that interact
with the modeled AMP-PNPMg2+ and the
associated hydrogen bonds are not ideally
modeled in the complex, and minor local
structural changes will be required to opti-
mally accommodate a bound nucleotide.
Asp101 is spatially equivalent to Glu70 in
SaCoaA, but it does not act as an essential
catalytic base.The PaCoaAATP model reveals that the interactions
of SaCoaA and PaCoaA with the adenine ring of the
bound nucleotide are significantly different (Figure 6).
In SaCoaA, the adenine moiety is tightly bound and is
sandwiched between Leu11 on b2 and Tyr137 at the N
terminus of a5 (Figure 6A). However, in PaCoaA, the N
terminus of a5 is much farther away from the putative
adenine binding site, and this side of the pocket opens
into a cavity lined by four arginine residues, 150, 154,
168, and 169 (Figure 6B). This open cavity does not sup-
port tight interactions with the adenine ring, and it is
consistent with the high Km for ATP and the lack of nu-
cleotide specificity (Figure S2B). In this respect, it may
be significant that the orientation of helix a5 represents
one of the more obvious structural differences between
PaCoaA and SaCoaA (Figures 2A and 2C). The Sa-
CoaA[Y137A] and SaCoaA[L11A] substitutions were
made to verify the roles of these side chains in adenine
binding. Both mutants had compromised catalytic activ-
ity, but only L11A showed a significantly increased KD
for the environmentally sensitive fluorescence of TNP-
ATP (Plesniak et al., 2002; Vanoye et al., 2002) (Figures
5A and 5B). Undetectable enhancement in the TNP-
ATP fluorescence in the presence of PaCoaA prevented
analysis of this enzyme.
The Pantothenate Binding Sites
In the PaCoaAPan binary complex, the two monomers
are essentially identical, and the a carbons can be
superimposed with an rmsd of 0.72 A˚. The only signifi-
cant difference occurs between residues 154 and 158,where the main chain and the side chain of His156
have different conformations. This region is disordered
in monomer A of the apo PaCoaA structure. Comparison
of the PaCoaA and PaCoaAPan structures does not re-
veal significant changes in the dimer arrangement, but
domains I and II are in a more ‘‘closed’’ conformation
in the complex. Pantothenate binds in a buried pocket
at the dimer interface, and it is oriented such that the
C40 hydroxyl group is adjacent to the paired P loop re-
gion at the center of the molecule (Figure 7A). Secondary
structure elements that contribute to the binding pocket
include strands b7 and b8, the N terminus of helix a3, the
extended loop between b5 and a3, the N terminus and
the associated loop of a60, and the C terminus and the
associated loop of a40. The latter region in monomer
A is the segment that becomes ordered in the binary
complex.
An important feature of the complex is that both ends
of pantothenate are involved in specific interactions
(Figure 7A). At one end, the C1 carboxyl group forms mul-
tiple interactions with the side chains of Tyr92, Arg102,
and Thr1800. Gly99 has a key role in the pocket by provid-
ing both space and a backbone amide nitrogen that do-
nates an additional hydrogen bond to the C1 carboxyl
group. At the other end, the C20 and C40 hydroxyl groups
are hydrogen bonded to the side chain of Asp101, and
the C40 hydroxyl also interacts via a water molecule
with the side chain of His1560 in monomer A. Asn9 is ab-
solutely conserved in 12 type III CoaA sequences, and it
is a characteristic feature of this class of enzymes (Brand
and Strauss, 2005). This residue replaces the second
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SaCoaA and PaCoaA
(A) Binding of the ATP analog TNP-ATP to a panel of SaCoaA mu-
tants. The identities of the individual mutant proteins are listed in (B).
(B) Activity of SaCoaA mutants. Each mutant was expressed and
purified, and their activities and TNP-ATP binding characteristics
were determined.
(C) Activity of PaCoaA mutants. Each mutant was expressed, puri-
fied, and assayed for kinase activity.
The data are the mean values from two determinations, and the error
bars represent the standard error.glycine in the P loop DxGG(T,S)T(S,G)xxK(R,C) motif,
and modeling suggests that the side chain mediates ad-
ditional interactions with the g-phosphate moiety of the
bound nucleotide (Figure 4B). However, our structure re-
veals that the OD1 oxygen of Asn9 also forms a key hy-
drogen bond to the carbonyl oxygen of pantothenate
through a structured water molecule (Figures 4B and
7A). This structured water molecule is further anchored
by hydrogen bonds to the side chain of Thr1570 and the
backbone carbonyl oxygen of Val55. The poor activity
of the mutant PaCoaA[N9G] is therefore related to both
Pan and phosphate binding (Figure 5C), whereas the re-
duced activity of mutant PaCoaA[T157A] is only related
to Pan binding (Figure 5C). Finally, the pantothenate
Figure 6. The Adenine Binding Sites of SaCoaA and PaCoaA
(A) SaCoaA containing the AMP-PNPMg2+ molecule from the crys-
tal structure (gray carbons in stick representation) is shown; the in-
teractions of the adenine ring with Tyr137 and Leu28/Leu11 are also
shown. Gln125 forms a hydrogen bond with the ribose hydroxyl.
(B) PaCoaA is shown with the adenine from the SaCoaA structure
modeled into the active site. The adenine projects into a large cavity,
created by the twisting of helix a5 relative to SaCoaA, that is lined
with arginine residues. The specific hydrophobic interactions with
the adenine ring that are common in kinases are not evident in
PaCoaA.
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(A) A stereoview of the PaCoaAPan binary complex showing the major hydrogen bonding and van der Waals interactions described in the text.
The pocket lies at the dimer interface, and Pan is shown with cyan carbons in stick representation. Note that the carboxyl terminal end of Pan
(top) is fully enclosed by the protein.
(B) Modeling of pantothenate into the SaCoaA structure. The binding pocket is open to solvent, allowing the pantothenamide antimetabolites
with extensions on the carboxy terminus of pantothenate to be accommodated.makes van der Waals contacts with the side chains of
Val55, Ile142, and Ile1600.
The structure of the SaCoaAPan complex was not
obtained, but the close structural homology to PaCoaA
allows us to generate a model (Figure 7B). The model re-
veals that the binding pocket in SaCoaA is not enclosed
by the dimer interface, but is exposed to the solvent.
This key distinction is the result of the different mono-
mer-monomer arrangement in the SaCoaA dimer and
the lack of the extended loop between b5 and a3. An im-
portant feature of the proposed SaCoaAPan binary
complex is that the terminal C1 carboxyl group is fully
exposed and does not interact with the protein apart
from a possible salt bridge interaction with an arginine
side chain (R113). The different architectures of the pan-
tothenate binding pockets in PaCoaA and SaCoaA have
important implications for the catalytic mechanisms of
the two proteins and their ability to bind and process
the pantothenamides.
The CoaAATPPan Ternary Complex
and the Catalytic Mechanism
By structurally aligning the SaCoaAAMP-PNP and
PaCoaAPan complexes, it was possible to generate
a model of the CoaAATPPan ternary complex for
each enzyme. The locations of the two substrates within
the enzymes are shown in Figure 2, and close-ups of the
active site regions are shown in Figure 4. Confidence in
both models derives from the close approach of the ATP
g-phosphate to the C40 hydroxyl of pantothenate, to
which it will be transferred in the enzyme mechanism.
Many kinases possess a Glu or Asp residue that func-
tions as a catalytic base to activate the hydroxyl of the
substrate for attack on the g-phosphate of ATP (Cleland
and Hengge, 1995; Mildvan, 1997). In EcCoaA, the cata-
lytic base is Asp127 (Ivey et al., 2004). In SaCoaA, muta-
genesis of Glu70 to alanine abolished enzymatic activity(<0.01% of wild-type), consistent with this residue play-
ing this critical role (Figure 5B). Asp101 in PaCoaA is
structurally equivalent to Glu70 in SaCoaA (Figure 4B);
however, the PaCoaA[D101A] mutant retained 20% of
wild-type activity (Figure 5C), and this result is not con-
sistent with a critical role for Asp101 in catalysis. This
observation is reminiscent of the structurally related ki-
nase, Hsc70, which has two candidate residues for the
catalytic base: Glu175 based on the hexokinase homol-
ogy and Asp206 based on actin. Hsc70 activity is 10% of
the wild-type when either residue is mutated to serine or
the respective amides (Wilbanks et al., 1994). The only
other candidate for the catalytic base in PaCoaA, even
postulating a large conformational change upon ATP
binding, is the imidazole ring of His156, which forms
a water-mediated hydrogen bond with the C40-OH of
pantothenate in monomer B. However, this interaction
is not seen in monomer A, and the PaCoaA[H156A] mu-
tant retains wild-type activity (Figure 5C). These results
suggest that the type III bacterial CoaAs are mechanis-
tically distinct from the type I and II enzymes and that
they have active sites that more closely resemble that
of Hsc70.
The structure of the Hsc70ADPPi (Wilbanks and
McKay, 1995) shows that the nucleotide phosphates en-
gage the adjacent P loops in the two kinase domains in
the same way that AMP-PNP binds to SaCoaA. How-
ever, Hsc70 is more similar to PaCoaA than to SaCoaA.
Asp121 in the ‘‘pseudo P loop’’ ofPaCoaA is replaced by
an asparagine (Asn96) in SaCoaA (Figure 4). An aspar-
tate is also present at this location in Hsc70 (Asp199),
where it interacts with a potassium ion that, in turn, inter-
acts with the coordination shell of the Mg2+ ion that
bridges the b-phosphate and the free phosphate (spa-
tially equivalent to the g-phosphate) (Figure 4B). The
K+ ion is also coordinated by the side chain of a threonine
in Hsc70 (Thr204) that occupies the same position as the
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plex. There is no equivalent location for a monovalent
cation in the SaCoaAAMP-PNP complex (Figure 4A).
The Hsc70[D199S] mutant displays a 100-fold reduction
in kcat with respect to the wild-type enzyme (Wilbanks
et al., 1994), and the structure reveals the loss of K+
from site 2 and a distortion of the octahedral coordina-
tion of Mg2+ (Johnson and McKay, 1999). Asp121 repre-
sents the prime candidate for the coordination of the
monovalent cation in PaCoaA. This residue is in a posi-
tion that is predicted to modulate the interaction be-
tween the monovalent cation and the g-phosphate
(Figure 4B), and the absence of activity in the Pa-
CoaA[D121A] mutant (Figure 5C) underscores the im-
portance of K+/NH4
+ binding in catalysis. Monovalent
cation-dependent kinases represent a distinct class of
kinases, and crystal structures reveal that K+ and Mg2+
interact with the triphosphate moiety of ATP to facilitate
the ATP binding and phosphoryl transfer (Di Cera, 2006).
Hsc70 is an accepted member of this subfamily, and,
based on our structural and catalytic analyses, PaCoaA
is also.
Enzymatic phosphoryl transfer reactions lie along a re-
action path that is characterized as being either associa-
tive in one extreme or dissociative in the other (Cleland
and Hengge, 1995; Mildvan, 1997). Our data suggest
that in PaCoaA the stabilization of the metaphosphate
leaving group by the electrostatic interactions between
the g-phosphate of ATP and the K+/NH4
+ and Mg2+ cat-
ions is more important to the phosphoryl transfer than
substrate activation for nucleophilic SN2 attack by a gen-
eral base. This hypothesis leads to the conclusion that
PaCoaA has a more dissociative mechanism for phos-
phoryl transfer compared to other kinases, like EcCoaA,
which have an associative character (Cleland and
Hengge, 1995; Ivey et al., 2004; Mildvan, 1997). In addi-
tion, the position of the pantothenate binding site in Pa-
CoaA ‘‘above’’ the cleft in which ATP binds and the fact
that the enclosed Pan site is accessible only by passing
through the ATP site strongly suggest an ordered mech-
anism with pantothenate binding first to the enzyme.
This is in contrast to EcCoaA, which also operates via
an ordered mechanism, but with ATP as the leading
substrate (Song and Jackowski, 1994). In the case of
SaCoaA, the different dimer interface creates two sol-
vent-exposed openings to the active site, and it is
likely that ATP enters from one direction and Pan binds
through the other opening in a nonsequential mecha-
nism. Finally, kinases typically display a conformational
closing of the active site cleft to exclude water during
phosphoryl transfer. Although this is likely to occur
upon formation of the ternary complex for which we do
not have a structure, it is relevant that the Pan bound
form of PaCoaA is in a more closed conformation, and
a similar interdomain movement has recently been re-
ported for Hsc70 (Jiang et al., 2005).
Role of PaCoaA in the P. aeruginosa
Resistance to N5-Pan
Pantothenamides inhibit E. coli and S. aureus growth by
blocking fatty acid biosynthesis (Leonardi et al., 2005a;
Zhang et al., 2004). Pantothenamide phosphorylation
by the type I and type II CoaAs allows these compounds
to enter the CoA biosynthetic pathway, to be metabo-lized to inactive CoA analogs, and to be incorporated
into acyl carrier protein. PaCoaA was unable to phos-
phorylate N5-Pan in vitro, and P. aeruginosa was resis-
tant to pantothenamide growth inhibition in a broth mi-
crodilution assay (Leonardi et al., 2005a; Zhang et al.,
2004). We verified that PaCoaA could be solely respon-
sible for pantothenamide resistance by using the E. coli
strain DV70 (coaA(Ts)) mutant that is unable to grow at
42C due to the inactivation of EcCoaA (Vallari and
Rock, 1987). Control strains were obtained by trans-
forming strain DV70 with either pPJ161, a vector harbor-
ing the E. coli coaA gene (Rock et al., 2003), or with the
empty vector, and the minimum inhibitory concentration
for N5-Pan was determined at 42C (Figure S3A). Ex-
pression of wild-type EcCoaA exacerbated the toxic
effect of the pantothenamide, consistent with an in-
creased flux of antimetabolite through CoA biosynthe-
sis. Conversely, expression of PaCoaA supported
pantothenamide-resistant growth of strain DV70 at 42C
(Figure S3A). The presence of a type I CoaA in addition
to a type III CoaA, as in B. subtilis (Brand and Strauss,
2005; Yocum and Patterson, 2004), is sufficient to
induce growth inhibition by the pantothenamides (data
not shown). These data demonstrated that type III
CoaAs are able to confer pantothenamide resistance if
they are the only functional pantothenate kinase.
P. aeruginosa is notoriously resistant to many antibi-
otics, and we therefore determined the N5-Pan sensitiv-
ity of strain PAO1 transformed with pRL012, a pUCP20-
derived vector (West et al., 1994) harboring the E. coli
coaA gene. P. aeruginosa was resistant to N5-Pan
even when expressing EcCoaA capable of phosphory-
lating the antimetabolite (Figure S3B). The expression
of EcCoaA in the P. aeruginosa/pRL012 lysate was con-
firmed by assaying the type I pantothenate kinase
activity in the absence of monovalent cations (Fig-
ure S3B, inset). These results demonstrated that P. aer-
uginosa was resistant to the pantothenamides for two
reasons: the pantothenate analogs were not taken up
by the pathogen, and they were not phosphorylated by
PaCoaA.
Our structure of the PaCoaAPan complex provides
an explanation for the resistance of this enzyme to pan-
tothenate analogs. The pantothenamides have substitu-
ents that modify the carboxyl (C1) end of pantothenate,
and the tight binding pocket cannot accommodate
these substituents. In contrast, this end of the
SaCoaAPan binding pocket is fully exposed and able
to bind the extended analogs.
Insights into Human PanK2 Structure and Function
The inherited PKAN neurodegenerative disorder is linked
to mutations in the humanPANK2 gene. All four isoforms
of human pantothenate kinases have a common cata-
lytic core domain, which shows >80% sequence identity
between PanK1a, PanK1b, PanK2, and PanK3 (Ho¨rtna-
gel et al., 2003; Rock et al., 2002; Zhang et al., 2005),
and they also have amino acid sequences inserted be-
tween strands b2 and b3 and between helices a1 and
a2 of SaCoaA (Figure 1A). The eukaryotic PanKs differ
from SaCoaA in that they are subject to feedback inhibi-
tion by CoA and its thioesters (Leonardi et al., 2005b),
and these inserted sequences may correspond to the
structural elements required for acetyl-CoA regulation
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mutants [K13A] and [E70A] are equivalent to the PanK2
point mutants [K224A] and [E338A], and these PanK2
mutants are inactive (Figure S4). Similarly, mutation of
the PanK2 Leu222 to Ala, equivalent to Leu11 inSaCoaA,
did not inactivate the enzyme. This supports both the
structural and functional conclusions that SaCoaA and
PanK2 are closely related. There are three amino acids
that are identical in SaCoaA and PanK2 and that are mu-
tated in PKAN patients (Figure 1A). The most common
mutation is PanK2[G521R], which is catalytically inactive
and fails to fold properly (Zhang et al., 2006). Gly521 cor-
responds to Gly224 of SaCoaA, located in the loop be-
tween strand b9 and 3/10 helix a8 (Figure 8), and it has
both functional and structural roles. Functionally, the ab-
sence of a side chain on Gly224 provides space for the
binding of Mg2+ and the phosphate groups of ATP. Struc-
turally, Gly224 is located at the N terminus of helix a8 and
may be important in folding. This conclusion is consis-
tent with the observation that SaCoaA[G224R] is insolu-
ble, reflecting the properties of PanK2[G521R]. A less
common PKAN mutation is PanK2[G219V], which is
also catalytically inactive (Zhang et al., 2006). Gly219 of
human PanK2 corresponds to Gly8 of SaCoaA, located
in the P loop between strands b1 and b2 (Figure 8). This
residue creates space for the binding of the ATP phos-
phates, and the introduction of a side chain would inter-
fere with ATP binding.SaCoaA[G8V] did not fold properly
and was recovered as an insoluble precipitate. Finally,
Leu563 in human PanK2 corresponds to Leu263 of
SaCoaA, located at the end of the C-terminal helix. The
Figure 8. PKAN-Linked Mutations Mapped onto the SaCoaA
Structure
In the SaCoaA structure, AMP-PNP is represented with gray carbons
and the Mg2+ is a green sphere. Residues Gly8 and Gly224 corre-
spond to residues Gly219 and Gly521 in human PanK2 and are lo-
cated in loops that bracket the ATP binding site. These glycines are
important to the structure of the ATP binding fold, and the absence
of a side chain allows room for the nucleotide to bind. Leu263,
located in helix a8, corresponds to Leu563 in PanK2 and interacts
with strand b1 to position the conserved DxGG(T,S)T(S,G)xxK(R,C)
motif to bind the phosphates of the nucleotide.PanK2[L563P] mutant is catalytically inactive (Figure S4),
and the SaCoaA[L263P] mutant is catalytically compro-
mised (Figure 5B). In the SaCoaA structure, the side
chain of Leu263 interacts with the backbone of strand
b1 (Figure 8), which contains the Mg2+-coordinating
Asp6 and the phosphate binding Lys13 (Figure 4A). The
substitution of Leu263 with proline is predicted to alter
the orientation of strand b1 and directly affect the
structure of the ATP binding pocket. Indeed, the
SaCoaA[L263P] mutant has a considerably higher KD
for TNP-ATP (Figure 5A), accounting for its lower cata-
lytic activity.
Experimental Procedures
Materials and Plasmid Construction
Materials and plasmid construction are described in the Supple-
mental Data.
Protein Expression and Purification
Protein expression and purification are described in the Supplemen-
tal Data.
Crystallization
Cocrystals of the Se-Met SaCoaA with AMP-PNP and Mg2+ were
grown by the sitting drop vapor diffusion method. Prior to crystalliza-
tion, the protein was incubated overnight with 30 mM AMP-PNP and
30 mM MgCl2. Typically, 1 ml precipitant solution was added to 1 ml
protein, and the mixture was allowed to equilibrate over 1 ml precip-
itant solution of 28% (w/v) PEG 2000 MME and 0.1 M bis-Tris (pH 6.5),
at 18C. After several days, hexagonal crystals appeared and were
allowed to grow for 1 week. All crystals were cryoprotected in the
50/50 mixture of Paratone-N and mineral oil and were flash frozen
in liquid nitrogen.
Crystals of Se-Met PaCoaA were grown by using the hanging-
drop vapor diffusion technique. Hanging drops were prepared by
mixing 4 ml protein solution with 1 ml water and were allowed to equil-
ibrate over water at 18C. A crystal of the Pan bound Se-Met enzyme
was obtained by soaking the PaCoaA crystal in 40 mM Tris-HCl (pH
7.5), 1 mM DTT, 1 mM EDTA, and 10 mM pantothenate for 1 day at
18C. All crystals were cryoprotected in 25 mM Tris-HCl (pH 7.5),
0.5 mM DTT, 26% ethylene glycol, and 26% glycerol and were flash
frozen in liquid nitrogen.
Data Collection and Structure Determination
of the SaCoaAAMP-PNP Complex
Data were collected on the Advanced Photon Source (beamline 19-
BM) at the Argonne National Laboratory. Two data sets were col-
lected at 100K for the Se-Met protein crystal, and one data set
was collected for a native crystal. Diffraction data were integrated,
reduced, and scaled with DENZO and SCALEPACK (Otwinowski
and Minor, 1997). The crystals belonged to space group P63 with
unit cell dimensions of a = 104.0 A˚ and c = 85.7 A˚. We used the pro-
gram SOLVE (Terwilliger and Berendzen, 1999) to scale two wave-
length data sets together, to locate selenium positions, and to calcu-
late the protein phase angles. The model was completed in several
repetitions of manual building with O (Jones et al., 1991) and crystal-
lographic refinement with REFMAC5 (Murshudov et al., 1999). The fi-
nal refinement statistics are shown in Table S1. Accessible and bur-
ied surface areas were calculated by using the program AREAIMOL
(CCP4, 1994) with a probe radius of 1.4 A˚.
Data Collection and Structure Determination
of the Apo and Pan Bound PaCoaA
MAD data sets were collected at the Southeast Regional Collabora-
tive Access Team (SER-CAT) 22-BM beamline at the Advanced
Photon Source, Argonne National Laboratory. Three wavelengths
0.9795 A˚ (the peak), 0.9797 A˚ (the inflection), and 0.9718 A˚ (the
remote) were selected based on the fluorescence scan of the Se K
absorption edge. The higher-resolution data for PaCoaA and
PaCoaAPan were collected at the (SER-CAT) 22-ID beamline. All
Structure
1260data sets were collected at 100K and were processed by using the
HKL2000 program package (Otwinowski and Minor, 1997).
The program SOLVE (Terwilliger and Berendzen, 1999) was used
to locate the 12 selenium sites and to calculate initial phases in the
resolution range of 50–2.5 A˚. The program RESOLVE (Terwilliger,
2000) was used for density modification, and all of the ordered res-
idues could be built into the resulting electron density map by using
Xtalview (McRee, 1999). The PaCoaA structure was refined to 2.2 A˚
resolution with the higher-resolution data sets by using the program
CNS (Brunger et al., 1998). The crystal asymmetric unit contained
one copy of the biological dimer. Pertinent data collection, phasing,
and refinement statistics are shown in Table S2. The PaCoaA and
PaCoaAPan crystals were isomorphous, and the PaCoaAPan
structure was determined by direct refinement of the dimeric struc-
ture of PaCoaA against the 1.9 A˚ diffraction data obtained for the
PaCoaAPan binary complex. After the first round of refinement,
the Fo 2 Fc difference map clearly revealed strong positive density
for pantothenate and also showed residues 155–163, which were
not visible in one of the subunits of the apo PaCoaA structure.
Pertinent statistics are also shown in Table S2. The program
PROCHECK (Laskowski et al., 1993) was used to evaluate the quality
of the structures. All of the figures were produced by using
MOLSCRIPT (Kraulis, 1991) and were rendered with RASTER3D
(Merritt and Bacon, 1997).
Analytical Gel Filtration and Ultracentrifugation
Analytical gel filtration and ultracentrifugation are described in the
Supplemental Data.
Kinetics, Enzymatic, and ATP Binding Assays
Kinetics, enzymatic, and ATP binding assays are described in the
Supplemental Data.
Expression of the Human PanK2 Mutants
Expression of the human PanK2 mutants is described in the Supple-
mental Data.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
two crystallographic tables, and four additional figures and are
available at http://www.structure.org/cgi/content/full/14/8/1251/
DC1/.
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